Clinical Trial Update: SW-682 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update indicates SW-682 for advanced solid tumors, including malignant mesothelioma, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Solid Tumors

Drugs mentioned

• SW-682

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Advanced Solid Tumor, Mesothelioma, Malignant | Phase 1 | Status: RECRUITING